These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22235204)

  • 1. Towards a "Sample-In, Answer-Out" Point-of-Care Platform for Nucleic Acid Extraction and Amplification: Using an HPV E6/E7 mRNA Model System.
    Gulliksen A; Keegan H; Martin C; O'Leary J; Solli LA; Falang IM; Grønn P; Karlgård A; Mielnik MM; Johansen IR; Tofteberg TR; Baier T; Gransee R; Drese K; Hansen-Hagge T; Riegger L; Koltay P; Zengerle R; Karlsen F; Ausen D; Furuberg L
    J Oncol; 2012; 2012():905024. PubMed ID: 22235204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.
    Molden T; Kraus I; Skomedal H; Nordstrøm T; Karlsen F
    J Virol Methods; 2007 Jun; 142(1-2):204-12. PubMed ID: 17379322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E6/E7 mRNA expression analysis: a test for the objective assessment of cervical adenocarcinoma in clinical prognostic procedure.
    Hovland S; Muller S; Skomedal H; Mints M; Bergström J; Wallin KL; Karlsen F; Johansson B; Andersson S
    Int J Oncol; 2010 Jun; 36(6):1533-9. PubMed ID: 20428778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of RNA from residual BD SurePath liquid-based cytology specimens and detection of HPV E6/E7 mRNA using the PreTectt HPV-Proofer assay.
    Dixon EP; King LM; Adams MD; Grønn P; Murphy PG; Brown CA; Brough GH; Skomedal H; Malinowski DP; Fischer TJ
    J Virol Methods; 2008 Dec; 154(1-2):220-2. PubMed ID: 18761379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of E6/E7 mRNAs of high risk human papilloma virus types by a commercial automatized NASBA assay in cervical swabs].
    Ardiç N; Oztürk O; Ergünay K; Sezer O
    Mikrobiyol Bul; 2009 Jul; 43(3):463-9. PubMed ID: 19795622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of HPV E6/E7 mRNA RT-qPCR for screening and diagnosis of cervical cancer with ThinPrep Pap test samples.
    Munkhdelger J; Kim G; Wang HY; Lee D; Kim S; Choi Y; Choi E; Park S; Jin H; Park KH; Lee H
    Exp Mol Pathol; 2014 Oct; 97(2):279-84. PubMed ID: 25102300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer.
    Ratnam S; Coutlee F; Fontaine D; Bentley J; Escott N; Ghatage P; Gadag V; Holloway G; Bartellas E; Kum N; Giede C; Lear A
    J Clin Microbiol; 2010 Aug; 48(8):2779-85. PubMed ID: 20573862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleic acid sequence-based amplification assay for human papillomavirus mRNA detection and typing: evidence for DNA amplification.
    Boulet GA; Micalessi IM; Horvath CA; Benoy IH; Depuydt CE; Bogers JJ
    J Clin Microbiol; 2010 Jul; 48(7):2524-9. PubMed ID: 20463156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus DNA and E6/E7 mRNA testing as triage in liquid-based cytology samples from primary screening.
    Andersson S; Mints M; Weiderpass E; Johansson B
    Curr Pharm Des; 2013; 19(8):1508-15. PubMed ID: 23072430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress on analysis of human papillomavirus by microchip capillary electrophoresis].
    Lin X; Wang C; Lin JM
    Se Pu; 2020 Oct; 38(10):1179-1188. PubMed ID: 34213114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology.
    Rijkaart DC; Heideman DA; Coupe VM; Brink AA; Verheijen RH; Skomedal H; Karlsen F; Morland E; Snijders PJ; Meijer CJ
    J Clin Microbiol; 2012 Jul; 50(7):2390-6. PubMed ID: 22553244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer.
    Castle PE; Dockter J; Giachetti C; Garcia FA; McCormick MK; Mitchell AL; Holladay EB; Kolk DP
    Clin Cancer Res; 2007 May; 13(9):2599-605. PubMed ID: 17473189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-specific human papillomavirus E6/E7 mRNA detection by real-time PCR improves identification of cervical neoplasia.
    Andersson E; Kärrberg C; Rådberg T; Blomqvist L; Zetterqvist BM; Ryd W; Lindh M; Horal P
    J Clin Microbiol; 2011 Nov; 49(11):3794-9. PubMed ID: 21940473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the NASBA nucleic acid amplification method for the detection of human papillomavirus type 16 E6-E7 transcripts.
    Smits HL; van Gemen B; Schukkink R; van der Velden J; Tjong-A-Hung SP; Jebbink MF; ter Schegget J
    J Virol Methods; 1995 Jul; 54(1):75-81. PubMed ID: 7559859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical performance of RNA isolated from BD SurePath™ cervical cytology specimens by the PreTect™ HPV-Proofer assay.
    Dixon EP; Grønn P; King LM; Passineau H; Doobay H; Skomedal H; Hariri J; Hay SN; Brown CA; Fischer TJ; Malinowski DP
    J Virol Methods; 2012 Nov; 185(2):199-203. PubMed ID: 22820075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
    Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
    J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a multiplex reverse transcript real-time PCR for E6/E7 mRNA detection of high-risk human papillomavirus.
    Pan C; Zhou J; Lyu J; Ren X
    J Med Microbiol; 2018 Oct; 67(10):1509-1514. PubMed ID: 30124401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hands-free sample preparation platform for nucleic acid analysis.
    Baier T; Hansen-Hagge TE; Gransee R; Crombé A; Schmahl S; Paulus C; Drese KS; Keegan H; Martin C; O'Leary JJ; Furuberg L; Solli L; Grønn P; Falang IM; Karlgård A; Gulliksen A; Karlsen F
    Lab Chip; 2009 Dec; 9(23):3399-405. PubMed ID: 19904407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MassARRAY spectrometry is more sensitive than PreTect HPV-Proofer and consensus PCR for type-specific detection of high-risk oncogenic human papillomavirus genotypes in cervical cancer.
    Basu P; Chandna P; Bamezai RN; Siddiqi M; Saranath D; Lear A; Ratnam S
    J Clin Microbiol; 2011 Oct; 49(10):3537-44. PubMed ID: 21813716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests.
    Aranda Flores CE; Gomez Gutierrez G; Ortiz Leon JM; Cruz Rodriguez D; Sørbye SW
    BMC Infect Dis; 2021 May; 21(1):504. PubMed ID: 34058992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.